تحذيرات السلامة

# العنوان نوع الخبر التاريخ رابط الخبر
198 Safety Signals Identified by SFDA (January - March) 2025 Signal
197 Safety Signal of Dulaglutide and the Risk of Pancreatic carcinoma Signal
196 Safety Signal of Escitalopram and the Risk of Cardiac arrest Signal
195 Safety Signal of Fingolimod and the Risk of Optic Neuritis Signal
194 Signal of Semaglutide and the Risk of Pancreatic carcinoma Signal
193 Safety Signal of Teclistamab and the Risk of Tumour lysis syndrome Signal
192 Safety Signal of Tacrolimus and the Risk of Kaposi’s sarcoma Signal
191 Safety Signal of Exenatide and the Risk of Thyroid cancer Signal
190 Safety Signal of COVID-19 Vaccine (Comirnaty) and the Risk of Liver injury Signal
189 Safety Signal of Rifampin and the Risk of Blood Uric Acid Increased Signal
Displaying 1 - 10 of 200